相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nrf2 in liver toxicology
Keiko Taguchi et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Sitagliptin protects liver against aflatoxin B1-induced hepatotoxicity through upregulating Nrf2/ARE/HO-1 pathway
Yujiang Ji et al.
BIOFACTORS (2020)
Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
Masahiro Shimokawa et al.
CANCER SCIENCE (2020)
α-Lipoic acid protects against microcystin-LR induced hepatotoxicity through regeneration of glutathione via activation of Nrf2
Lihong Gu et al.
ENVIRONMENTAL TOXICOLOGY (2020)
Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line
Daisuke Yasuda et al.
FREE RADICAL RESEARCH (2020)
TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
Yanfeng Liu et al.
NATURE COMMUNICATIONS (2020)
Cadmium Induces Acute Liver Injury by Inhibiting Nrf2 and the Role of NF-kappa B, NLRP3, and MAPKs Signaling Pathway
Chang Liu et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma
Hoi Wing Leung et al.
CANCER LETTERS (2020)
Hepatocyte-specific deficiency of Nrf2 exacerbates carbon tetrachloride-induced liver fibrosis via aggravated hepatocyte injury and subsequent inflammatory and fibrogenic responses
Hang Lyu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression
Yotaro Kudo et al.
CANCER CELL (2020)
Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis
Effi Haque et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis
Claudia Orru et al.
CANCERS (2020)
NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism
Douglas B. Fox et al.
NATURE METABOLISM (2020)
Potential Applications of NRF2 Inhibitors in Cancer Therapy
Emiliano Panieri et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
Clotilde Wiel et al.
CELL (2019)
GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone
Fan Yang et al.
EMBO JOURNAL (2019)
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase
Viraj R. Sanghvi et al.
CELL (2019)
Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis
Daniela Bender et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Galangin Activates Nrf2 Signaling and Attenuates Oxidative Damage, Inflammation, and Apoptosis in a Rat Model of Cyclophosphamide-Induced Hepatotoxicity
Saleem H. Aladaileh et al.
BIOMOLECULES (2019)
Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response
Yuning Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Chaperone-Mediated Autophagy in the Liver: Good or Bad?
Srikanta Dash et al.
CELLS (2019)
NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis
Haoyan Guo et al.
CANCER LETTERS (2019)
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
KLF9-dependent ROS regulate melanoma progression in stage-specific manner
Archis Bagati et al.
ONCOGENE (2019)
The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
Dongwei Xu et al.
FRONTIERS IN PHARMACOLOGY (2019)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma
Bing Tian et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Activation of p62-keap1-Nrf2 antioxidant pathway in the early stage of acetaminophen-induced acute liver injury in mice
Zhenyu Shen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation
Hsiu-Yu Liu et al.
INVESTIGATIONAL NEW DRUGS (2018)
Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis
Claudia Orru et al.
JOURNAL OF HEPATOLOGY (2018)
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Antonio Cuadrado et al.
PHARMACOLOGICAL REVIEWS (2018)
Ethyl pyruvate can alleviate alcoholic liver disease through inhibiting Nrf2 signaling pathway
Fei Shen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Chemopreventive Activities of Sulforaphane and Its Metabolites in Human Hepatoma HepG2 Cells
Peng Liu et al.
NUTRIENTS (2018)
Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus Cell Culture
Yucel Aydin et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
NRF2 mitigates acute alcohol-induced hepatic and pancreatic injury in mice
Jing Sun et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Curcumin confers hepatoprotection against AFB(1)-induced toxicity via activating autophagy and ameliorating inflammation involving Nrf2/HO-1 signaling pathway
Ishfaq Muhammad et al.
MOLECULAR BIOLOGY REPORTS (2018)
Nrf2 in alcoholic liver disease
Jing Sun et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
A catalogue of somatic NRF2 gain-of-function mutations in cancer
Michael John Kerins et al.
SCIENTIFIC REPORTS (2018)
Isoorientin Ameliorates APAP-Induced Hepatotoxicity via Activation Nrf2 Antioxidative Pathway: The Involvement of AMPK/Akt/GSK3β
Xiaoye Fan et al.
FRONTIERS IN PHARMACOLOGY (2018)
Dysregulation of Nrf2 in Hepatocellular Carcinoma: Role in Cancer Progression and Chemoresistance
Azhwar Raghunath et al.
CANCERS (2018)
Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2)
Ritu S. Sharma et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis
Haruhiko Takeda et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
Rui Li et al.
JOURNAL OF IMMUNOLOGY (2017)
Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
Kouhei Tsuchida et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma
Derek Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Global trends and predictions in hepatocellular carcinoma mortality
Paola Bertuccio et al.
JOURNAL OF HEPATOLOGY (2017)
Brusatol overcomes chemoresistance through inhibition of protein translation
Bryan Harder et al.
MOLECULAR CARCINOGENESIS (2017)
Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH
Pierluigi Ramadori et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
Albena T. Dinkova-Kostova et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2017)
Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22
Ya-Hui Ni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis
Maria Maddalena Angioni et al.
ONCOTARGET (2017)
Camptothecin suppresses NRF2-ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs
Feng Chen et al.
BRITISH JOURNAL OF CANCER (2017)
Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cells
Chin-Kai Tseng et al.
ANTIVIRAL RESEARCH (2017)
Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis
Hoang Kieu Chi Ngo et al.
CANCER RESEARCH (2017)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Molecular basis of alcoholic fatty liver disease: From incidence to treatment
Francislaine A. R. Livero et al.
HEPATOLOGY RESEARCH (2016)
Application of Mass Spectrometry Profiling to Establish Brusatol as an Inhibitor of Global Protein Synthesis
Steffan Vartanian et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules
Marta Anna Kowalik et al.
ONCOTARGET (2016)
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
Anju Singh et al.
ACS CHEMICAL BIOLOGY (2016)
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Atsushi Umemura et al.
CANCER CELL (2016)
Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
Xupeng Bai et al.
DRUG METABOLISM REVIEWS (2016)
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis
Da Hyun Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Pathogenesis of Nonalcoholic Steatohepatitis
Mariana Verdelho Machado et al.
GASTROENTEROLOGY (2016)
Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma
Takayuki Shimizu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2016)
Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway
Jung-Sheng Yu et al.
PLOS ONE (2016)
Generation of a New Model Rat: Nrf2 Knockout Rats Are Sensitive to Aflatoxin B1 Toxicity
Keiko Taguchi et al.
TOXICOLOGICAL SCIENCES (2016)
The Dual Roles of NRF2 in Cancer
Silvia Menegon et al.
TRENDS IN MOLECULAR MEDICINE (2016)
p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
Tetsuya Saito et al.
NATURE COMMUNICATIONS (2016)
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
Marta Anna Kowalik et al.
ONCOTARGET (2016)
Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma
Jiang Chen et al.
CANCER MEDICINE (2016)
Regulation of Sirt1/Nrf2/TNF-α signaling pathway by luteolin is critical to attenuate acute mercuric chloride exposure induced hepatotoxicity
Daqian Yang et al.
SCIENTIFIC REPORTS (2016)
A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer
Michael J. Bollong et al.
ACS CHEMICAL BIOLOGY (2015)
Nrf2 is essential for timely M phase entry of replicating hepatocytes during liver regeneration
Yuhong Zou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma
Mingxin Zhang et al.
BMC CANCER (2015)
MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil
Liang Shi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Nrf2 in health and disease: current and future clinical implications
Othman Al-Sawaf et al.
CLINICAL SCIENCE (2015)
Sulforaphane protects against acetaminophen-induced hepatotoxicity
Jung-Ran Noh et al.
FOOD AND CHEMICAL TOXICOLOGY (2015)
Nrf2, but not -catenin, mutation represents an early event in rat hepatocarcinogenesis
Patrizia Zavattari et al.
HEPATOLOGY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation
B. Liu et al.
CELL DEATH & DISEASE (2015)
The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
Silvia S. Chambel et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?
Akinobu Takaki et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway
Liang Shi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
Song Chian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis
Richard Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Shasha Tao et al.
CANCER RESEARCH (2014)
Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver
Min Hu et al.
CELL CYCLE (2014)
Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells
C. Qian et al.
FREE RADICAL RESEARCH (2014)
MicroRNA/Gene Profiling Unveils Early Molecular Changes and Nuclear Factor Erythroid Related Factor 2 (NRF2) Activation in a Rat Model Recapitulating Human Hepatocellular Carcinoma (HCC)
Annalisa Petrelli et al.
HEPATOLOGY (2014)
Activated Nrf2 Impairs Liver Regeneration in Mice by Activation of Genes Involved in Cell-Cycle Control and Apoptosis
Ulrike A. Koehler et al.
HEPATOLOGY (2014)
Nuclear Factor (Erythroid-Derived 2)-Like 2 Activation-Induced Hepatic Very-Low-Density Lipoprotein Receptor Overexpression in Response to Oxidative Stress Contributes to Alcoholic Liver Disease in Mice
Zhigang Wang et al.
HEPATOLOGY (2014)
Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice
Daniela C. Kroy et al.
JOURNAL OF HEPATOLOGY (2014)
Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy
Hong-Min Ni et al.
JOURNAL OF HEPATOLOGY (2014)
Overexpression of Nrf2 Protects against Microcystin-Induced Hepatotoxicity in Mice
Yuan-Fu Lu et al.
PLOS ONE (2014)
Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus
Kazuo Sugiyama et al.
PLOS ONE (2014)
Loss of Nrf2 in Mice Evokes a Congenital Intrahepatic Shunt That Alters Hepatic Oxygen and Protein Expression Gradients and Toxicity
John J. Skoko et al.
TOXICOLOGICAL SCIENCES (2014)
Nrf2 protects against furosemide-induced hepatotoxicity
Qiang Qu et al.
TOXICOLOGY (2014)
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism
Elisabetta Ceni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Lucidone Suppresses Hepatitis C Virus Replication by Nrf2-Mediated Heme Oxygenase-1 Induction
Wei-Chun Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Functions of autophagy in normal and diseased liver
Mark J. Czaja et al.
AUTOPHAGY (2013)
Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway
Ai-Mei Gao et al.
CARCINOGENESIS (2013)
The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression
Suna Zhou et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance
Suryakant K. Niture et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Identification of Driver Genes in Hepatocellular Carcinoma by Exome Sequencing
Sean P. Cleary et al.
HEPATOLOGY (2013)
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
Derrick M. Van Rooyen et al.
JOURNAL OF HEPATOLOGY (2013)
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
Yoshinobu Ichimura et al.
MOLECULAR CELL (2013)
Nrf2 deletion causes benign simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet
Chunhua Wang et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Emerging regulation and functions of autophagy
Patricia Boya et al.
NATURE CELL BIOLOGY (2013)
NRF2 Protection against Liver Injury Produced by Various Hepatotoxicants
Jie Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Toward clinical application of the Keap1-Nrf2 pathway
Takafumi Suzuki et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Yoichiro Mitsuishi et al.
CANCER CELL (2012)
Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
Suryakant K. Niture et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks
Yosuke Hirotsu et al.
NUCLEIC ACIDS RESEARCH (2012)
Nrf2 activation prevents cadmium-induced acute liver injury
Kai C. Wu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
The Keap 1-Nrf2 system in cancers: stress response and anabolic metabolism
Yoichiro Mitsuishi et al.
FRONTIERS IN ONCOLOGY (2012)
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn et al.
NATURE REVIEWS CANCER (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Succination of Keap1 and Activation of Nrf2-Dependent Antioxidant Pathways in FH-Deficient Papillary Renal Cell Carcinoma Type 2
Lisa Kinch et al.
CANCER CELL (2011)
Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
Julie Adam et al.
CANCER CELL (2011)
Autophagy-deficient mice develop multiple liver tumors
Akito Takamura et al.
GENES & DEVELOPMENT (2011)
Hepatitis C Virus Impairs the Induction of Cytoprotective Nrf2 Target Genes by Delocalization of Small Maf Proteins
Monica Carvajal-Yepes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Yoshihiro Inami et al.
JOURNAL OF CELL BIOLOGY (2011)
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Dongmei Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
HCV and HCC: Clinical Update and a Review of HCC-Associated Viral Mutations in the Core Gene
Jawad Ahmad et al.
SEMINARS IN LIVER DISEASE (2011)
Liver Regeneration after Partial Hepatectomy Critical Analysis of Mechanistic Dilemmas
George K. Michalopoulos
AMERICAN JOURNAL OF PATHOLOGY (2010)
Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice
Hirokazu Sugimoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Enhanced Hepatic Nrf2 Activation After Ursodeoxycholic Acid Treatment in Patients with Primary Biliary Cirrhosis
Kazuhito Kawata et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis
Sudhir Chowdhry et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Progenitor-Derived Hepatocellular Carcinoma Model in the Rat
Jesper B. Andersen et al.
HEPATOLOGY (2010)
p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
Ashish Jain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
Keiko Taguchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62
Alexandria Lau et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
Masaaki Komatsu et al.
NATURE CELL BIOLOGY (2010)
Targeting NRF2 signaling for cancer chemoprevention
Mi-Kyoung Kwak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Clinical Implications of Advances in the Basic Science of Liver Repair and Regeneration
S. J. Karp
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice
Melinda S. Yates et al.
CARCINOGENESIS (2009)
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide
Soona Shin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo:: Implications for the prevention of fetal alcohol spectrum disorders
Jian Dong et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury
Jutta Lamle et al.
GASTROENTEROLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance
Tobias A. Beyer et al.
EMBO JOURNAL (2008)
Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha
Xiu Jun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Different electrostatic Potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response
Kit I. Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway
Jonathan M. Maher et al.
HEPATOLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]quinoline
Yasuki Kitamura et al.
CANCER SCIENCE (2007)
Keap1 eye on the target: chemoprevention of liver cancer
Melinda Sue Yates et al.
ACTA PHARMACOLOGICA SINICA (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Keap1 recruits Neh2 through binding to ETGE and DLG motifs: Characterization of the two-site molecular recognition model
KI Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Coordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway
SB Cullinan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole
MS Yates et al.
CANCER RESEARCH (2006)
Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver
JM Maher et al.
DRUG METABOLISM AND DISPOSITION (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
K Iida et al.
CANCER RESEARCH (2004)
Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis
H Ikeda et al.
BIOCHEMICAL JOURNAL (2004)
Curcurnin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element
E Balogun et al.
BIOCHEMICAL JOURNAL (2003)
Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver
XH Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
M Ramos-Gomez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes
A Enomoto et al.
TOXICOLOGICAL SCIENCES (2001)
Regulated translation initiation controls stress-induced gene expression in mammalian cells
HP Harding et al.
MOLECULAR CELL (2000)
分享论文
